RATIO THERAPEUTICS

Serial Number 98802144
Registration 7857948
700

Registration Progress

Application Filed
Oct 15, 2024
Under Examination
Approved for Publication
May 20, 2025
Published for Opposition
May 20, 2025
Registered
Jul 8, 2025

Trademark Image

RATIO THERAPEUTICS

Basic Information

Serial Number
98802144
Registration Number
7857948
Filing Date
October 15, 2024
Registration Date
July 8, 2025
Published for Opposition
May 20, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 8, 2025
Registration
Registered
Classes
001 005

Rights Holder

Ratio Therapeutics, Inc.

03
Address
One Design Center Place
Ste 19-601
Boston, MA 02210

Ownership History

Ratio Therapeutics, Inc.

Original Applicant
03
Boston, MA

Ratio Therapeutics, Inc.

Owner at Publication
03
Boston, MA

Ratio Therapeutics, Inc.

Original Registrant
03
Boston, MA

Legal Representation

Attorney
Nicole Gage

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

9 events
Date Code Type Description Documents
Jul 8, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 8, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 20, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 20, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 14, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 21, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 17, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 16, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 15, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Small molecule chemical structures, namely, reagents for adhering radioactive agents to pharmaceutical compounds for scientific purposes; chemical agents for chelating radioisotopes
First Use Anywhere: Jul 7, 2022
First Use in Commerce: Jul 19, 2022
Class 005
Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers
First Use Anywhere: May 31, 2023
First Use in Commerce: May 31, 2023

Classification

International Classes
001 005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
No claim is made to the exclusive right to use "Therapeutics" apart from the mark as shown.